Cost-effectiveness of antiviral therapy in chronic hepatitis C (G1)
Updated HCV clinical guidelines placed direct acting agents (DAAs) as the preferable the first line regimens.The objective of the study was PE assessment of HCV therapy among G1 naïve patientsMethods: Analysis is based on data of randomized clinical trials and average price of HCV medicines from sta...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2016-02-01
|
| Series: | Žurnal Infektologii |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/450 |